New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

How do you decide which patients with chronic hypoparathyroidism you move from calcium and active vitamin D to PTH replacement therapy?

1 Answer
Mednet MemberInvited Expert
Endocrinology · Boston University School of Medicine
Answered on

My preference, if the patient has good insurance or has the ability to pay for the therapy, is PTH replacement therapy. Calcitriol plus calcium can work reasonably well in maintaining serum calcium concentrations. However, the major issue is the serum phosphate. Patients with a high-normal or elevat...

Join for free or sign in to see the full answer